Ovatools Logo OvaTools Andrology & Embryology Training Institute
Registration Now Open for Training Sessions

IGENOMIX and MedTech Offers Savings To GPO Members

Dear GPO Members,
We recently announced an exciting partnership between Igenomix and MedTech’s Group Purchasing Organization (GPO).This partnership offers access and discounts to the Igenomix Laboratories throughout the US for genetic testing in the IVF field including:
  • Endometrial Receptivity Assay (ERA)
  • Products of Conception Testing (POC)
  • Preimplantation Genetic Screening (PGS)/Comprehensive Chromosome Screening (CCS)
  • Preimplantation Genetic Diagnosis (PGD)
IGENOMIX is a bio-technology company providing advanced services in reproductive genetics. Its consolidated experience and advanced research capabilities make it one of the world leaders in this field and guarantee the provision of effective solutions tailored to different infertility problems through high quality testing using the latest technology (Next Generation Sequencing). With labs around the US (Miami, Los Angeles, New York) and Canada (Montreal), Igenomix is well placed to work with IVF centers around the US and Canada. In addition to the US market, Igenomix has labs around the world including its headquarter lab in Valencia (Spain) as well as labs in Mexico (Mexico City), Brazil (Sao Paulo), United Arab Emirates (Dubai), India (Delhi), England (London), Japan (Tokyo) and Argentina (Buenos Aires). Today Igenomix has over 200 employees covering laboratory, finance, market development, marketing and customer support.
For more information on Igenomix‘s genetic testing, please call 305-501-4948 or email infousa@igenomix.com and let them know you are a MedTech GPO Member.
Many GPO members have seen savings since our original announcement and would encourage a call to Igenomix for those not using the agreement for more information on savings to your practice and patients. 
Global NGS approach to improve IVF outcomes
An advanced technology applied to our tests which, individually or combined, increases reproductive success rates in your patients.